患者血液管理市場規模、佔有率和成長分析：按產品、組件、最終用戶和地區 - 2024-2031 年行業預測

2023年患者血液管理市場規模估值為137.9億美元，從2024年的146.6億美元成長到2032年的239億美元，在預測期內（2025-2032年）複合年成長率為6.30，預計將成長%。

在慢性病盛行率上升、外科手術數量增加以及人們對 PBM 益處的認知不斷提高的推動下，全球患者血液管理 (PBM) 市場正處於強勁成長軌道。這項策略方法旨在加強對需要輸血的患者的護理，最終改善結果並最大限度地減少對輸血的依賴。心血管疾病、癌症和血液疾病等慢性疾病是外科手術增加輸血需求的主要原因。然而，醫療保健提供者擴大實施 PBM 策略，以減少感染疾病和免疫反應等相關風險。這一轉變的重點是改善手術結果和減少併發症，從而推動市場對 PBM 解決方案的需求。此外，人們對輸血創新替代方案的認知不斷增強，全球 PBM 的採用也不斷增加。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 宏觀經濟指標
• 價值鏈分析
• 價格分析

病患血液管理市場規模：依產品分類

• 市場概況
• 裝置
• 血液處理設備
  • 離心式
  • 血球處理設備
• 輸血設備
  • 血漿分離裝置
  • 細胞救援系統
• 血液培養篩檢裝置
  • 自動血液培養系統
  • 支援設備
• 診斷和測試設備
  • 聚合酵素鏈鎖反應
  • 血液分析儀
  • 血型檢測儀
  • 次世代定序（NGS）平台
  • 其他
• 血液儲存裝置
  • 冰箱
  • 冷凍庫
• 配件
• 注射器和針頭
• 管瓶和管子
• 血袋
• 其他配件
• 試劑和套件
• 文化媒體
• 血型測定試劑
• 玻片染色
• 檢測試劑套件
• 其他
• 軟體
• 血庫和輸血軟體
• 其他

病患血液管理市場規模：依組成部分

• 市場概況
• 全血
• 血液成分

患者血液管理市場規模：依最終用戶分類

• 市場概況
• 醫院
• 血庫

病患血液管理市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Haemonetics Corporation（USA）
• Macopharma（France）
• Terumo Corporation（Japan）
• B. Braun SE（Germany）
• Grifols, SA（Spain）
• Asahi Kasei Corporation（Japan）
• BioMerieux SA（France）
• LivaNova PLC（UK）
• Fresenius Kabi AG（Germany）
• Roche Holding AG（Switzerland）
• Abbott Laboratories（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Danaher Corporation（USA）
• Siemens Healthineers（Germany）
• Johnson & Johnson（USA）
• Medtronic plc.（Ireland）
• BD（Becton, Dickinson and Company）（USA）
• Cardinal Health（USA）
• Teleflex Incorporated（USA）
• Stryker Corporation（USA）

結論和建議

Patient Blood Management Market size was valued at USD 13.79 Billion in 2023 and is poised to grow from USD 14.66 Billion in 2024 to USD 23.9 Billion by 2032, growing at a CAGR of 6.30% during the forecast period (2025-2032).

The global patient blood management (PBM) market is on a robust growth trajectory, fueled by rising chronic disease prevalence, an uptick in surgical procedures, and heightened awareness of PBM benefits. This strategic approach aims to enhance care for patients needing blood transfusions, ultimately improving outcomes and minimizing transfusion reliance. Chronic diseases like cardiovascular disorders, cancer, and blood disorders are major contributors to surgical needs, intensifying transfusion requirements. However, healthcare providers are increasingly implementing PBM strategies to mitigate associated risks such as infections and immune reactions. This shift emphasizes improving surgical results and reducing complications, propelling market demand for PBM solutions. Furthermore, awareness of innovative alternatives to transfusions is increasingly promoting the adoption of PBM practices on a global scale.

Top-down and bottom-up approaches were used to estimate and validate the size of the Patient Blood Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Patient Blood Management Market Segmental Analysis

Global Patient Blood Management Market is segmented by product, component, end user and region. Based on product, the market is segmented into instruments, blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, blood storage devices, accessories, syringes & needles, vials & tubes, blood bags, other accessories, reagents and kits, culture media, blood typing reagents, slide staining, assay kits, others, software, blood bank and transfusion software and others. Based on component, the market is segmented into whole blood and blood components. Based on end user, the market is segmented into hospitals and blood banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Patient Blood Management Market

The Patient Blood Management market is driven by significant advancements in transfusion medicine, which have transformed the landscape of blood management practices. Innovations in techniques and technologies have greatly enhanced the safety, efficiency, and effectiveness of blood transfusions. As a result, healthcare providers are increasingly embracing patient blood management strategies to optimize patient outcomes. These developments not only reduce the risks associated with transfusions but also foster a greater understanding of the importance of prudent blood usage. Consequently, the ongoing evolution in transfusion medicine is playing a pivotal role in propelling the growth of the Patient Blood Management market.

Restraints in the Patient Blood Management Market

The Patient Blood Management market faces several restraints, primarily due to the challenges associated with altering established transfusion practices. Transitioning towards these new management strategies requires a significant shift away from traditional methods and medical standards. This shift can be hindered by resistance to change from healthcare professionals, as well as the need to accommodate individual physician preferences. Moreover, ensuring that adequate training and education are provided to facilitate understanding and acceptance of these innovative practices poses additional hurdles. As a result, these factors collectively impede the broader implementation and acceptance of patient blood management methodologies in clinical settings.

Market Trends of the Patient Blood Management Market

In the global Patient Blood Management market, a notable trend is the heightened emphasis on personalized and evidence-based transfusion practices, driven by a growing awareness of the risks associated with indiscriminate blood use. Healthcare providers are increasingly adopting tailored transfusion strategies that align with individual patient needs and clinical conditions, steering away from the traditional one-size-fits-all approach. This shift not only aims to enhance patient safety by reducing the likelihood of transfusion reactions and infections but also seeks to lower healthcare costs through optimized blood utilization. Consequently, hospitals and healthcare systems are investing in technologies and training that support this patient-centric model, indicating a transformational shift in blood management practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Patient Blood Management Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Blood Processing Devices
  • Centrifuge
  • Blood Cell Processors
• Blood Transfusion Devices
  • Apheresis Machines
  • Cell Salvage Systems
• Blood Culture Screening Devices
  • Automated Blood Culture Systems
  • Supporting Equipment
• Diagnostic & Testing Instruments
  • Polymerase Chain Reaction
  • Hematology Analyzer
  • Blood Grouping Analyzers
  • Next-Generation Sequencing (Ngs) Platforms
  • Others
• Blood Storage Devices
  • Refrigerator
  • Freezers
• Accessories
• Syringes & Needles
• Vials & Tubes
• Blood Bags
• Other Accessories
• Reagents And Kits
• Culture Media
• Blood Typing Reagents
• Slide Staining
• Assay Kits
• Others
• Software
• Blood Bank And Transfusion Software
• Others

Global Patient Blood Management Market Size by Component & CAGR (2025-2032)

• Market Overview
• Whole Blood
• Blood Components

Global Patient Blood Management Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Blood Banks

Global Patient Blood Management Market Size & CAGR (2025-2032)

• North America (Product, Component, End User)
  • US
  • Canada
• Europe (Product, Component, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Component, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Component, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Component, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Haemonetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations